S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

NVIV InVivo Therapeutics Holdings Corporation

0.3207

0.00 (0.00%)

After Hours

Last Updated: 18:00:00

Delayed by 15 minutes

Form ARS - Annual Report to Security Holders

InVivo Therapeutics (NASDAQ:NVIV)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more InVivo Therapeutics Charts.

InVivo Therapeutics (NASDAQ:NVIV)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more InVivo Therapeutics Charts.

InVivo Therapeutics Holdings Corporation News

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Thursday 21 March 2024 (8 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (9 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Tuesday 13 February 2024 (9 months ago) • Edgar (US Regulatory)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Wednesday 7 February 2024 (9 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (9 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Tuesday 6 February 2024 (9 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 6 February 2024 (9 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 1 February 2024 (10 months ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Tuesday 5 December 2023 (12 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 1 December 2023 (12 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 30 November 2023 (12 months ago) • Edgar (US Regulatory)

More InVivo Therapeutics Holdings Corporation News Articles

Bnp Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions